ResultsNDTV Profit
Natco Pharma shares rally 9% despite weak Q2 results
Negative-67Company event
GreyOak summary
Natco Pharma shares surged 8.64% to Rs 882.45 despite reporting a 60.8% YoY drop in net profit to Rs 203 crore in Q2FY27. Revenue fell 29% to Rs 967 crore, and EBITDA margins compressed by 1,580 bps to 26.7%.
What it affects
- Natco PharmaNATCOPHARMNegative -67
Shares rallied 9% despite weak Q2 results.Rolling sentiment Negative -70
Source
Read the original at NDTV ProfitMore Natco Pharma news
- Natco Pharma Q2 profit drops 60.8% to ₹202.6 crBusiness Standard · Results ·
- Natco Pharma Q2 profit, revenue fall; dividend declaredCNBC-TV18 · Results ·
- Natco Pharma Q2 Profit Falls 61% to Rs 203 CrNDTV Profit · Results ·